“For women who initiate HT more than 10 or 20 years from menopause onset or when aged 60 years or older, the benefit-risk ratio appears less favorable than for…”.1
Umbrella
What may the Hormone Therapy and Aging Umbrella include?
Depending on the Source (DotS) this Umbrella may include:
- Hormone Replacement Therapy (HRT) and Aging/Prevention/Protection
- Hormone Therapy (HT) and Aging/Prevention/Protection
- Menopausal Hormone Therapy (MHT) and Aging/Prevention/Protection
Chronic Conditions
Is there an association between hormone therapy (HT) and the prevention of chronic conditions?
In December 2017, the (United States) Preventative Services Task Force (USPSTF) updated their 2012 recommendations about the use of HT in postmenopausal women for the primary prevention of chronic conditions.
In Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Recommendation Summary the USPSTF recommend:
The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal women”.2
In Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Recommendation Summary, the USPSTF recommend:
The USPSTF recommends against the use of estrogen alone for the primary prevention of chronic conditions in postmenopausal women who have had a hysterectomy”.3
Osteoporosis
How may osteoporosis be prevented?
In Menopause FAQs: Your Health After Menopause – Q. What can I do to prevent osteoporosis? the NAMS elaborate on
Heart Disease
How may heart disease be prevented?
In Menopause FAQs: Your Health After Menopause – Q. Do I have to start worrying about heart disease? the NAMS elaborate on:
Benefits and Risks
For older women, what is the HT benefit-risk ratio?
On page one in NAMS 2017 Position Statement Updates Guidelines for Hormone Therapy Use published 20 June 2017, the NAMS explain:
- “For women who initiate HT more than 10 or 20 years from menopause onset or when aged 60 years or older, the benefit-risk ratio appears less favorable than for younger women because of greater absolute risks of coronary heart disease, stroke, venous thromboembolism, and dementia”.6
On page one in Deciding About Hormone Therapy Use: Potential Risks published in June 2017, the NAMS also elaborate on:
- “As with all medications, HT is associated with some potential risks. For healthy women aged younger than 60 years with bothersome hot flashes who are within 10 years of menopause, the benefits of HT generally outweigh the risks. Hormone therapy might slightly increase your risk of stroke or blood clots in the legs or lungs (especially if taken in pill form). If started in women aged older than 65 years, HT might increase the risk of dementia. If you have a uterus and take estrogen with progestogen, there is no increased risk of cancer of the uterus. Hormone therapy (combined estrogen and progestogen) might slightly increase your risk of breast cancer if used for more than 4 to 5 years. Using estrogen alone (for women without a uterus) does not increase breast cancer risk at 7 years but may increase risk if used for a longer time”.7
Stop or Not
If I am an older woman, do I need to discontinue HT?
On page one in the NAMS 2017 Position Statement Updates Guidelines for Hormone Therapy Use published 20 June 2017 the NAMS elaborate on:
- “Hormone therapy does not need to be routinely discontinued in women aged older than 60 or 65 years and can be considered for continuation beyond age 65 years for persistent hot flashes, quality-of-life issues, or prevention of osteoporosis after appropriate evaluation and counseling of benefits and risks”.8
Health Care Provider
What if I would like to choose to use HT to prevent aging?
If you would like to choose to use HT to prevent aging, it may be in your best interest to also choose to talk to your health care provider about this.
One of the points of consensus about menopausal hormone therapy (MHT) in the Revised Global Consensus Statement on Menopausal Hormone Therapy: Section B: General Principles Governing the Use of MHT – endorsed by seven menopause-related organizations – published online 20 June 2016, is:
- “The option of MHT is an individual decision in terms of quality of life and health priorities as well as personal risk factors such as age, time since menopause and the risk of VTE, stroke, ischemic heart disease and breast cancer. MHT should not be recommended without a clear indication for its use”.9
What is VTE?
VTE can be an abbreviation for Venous Thromboembolism.
On page two in the NAMS 2017 Position Statement Updates Guidelines for Hormone Therapy Use published 20 June 2017 the NAMS’s current president reassures older women and elaborates on:
Health Topics A-Z
Where may I find Health Topics related to Hormone Therapy and Aging?
In Health Topics A-Z you may find:
Health Topics A-Z
- Healthy Aging
- Hormone Therapy
- Hormone Therapy 2016 Revised Global Consensus Statement
- Hormone Therapy 2017 Update for Chronic Conditions
- Hormone Therapy Benefits and Risks
- Hormone Therapy Postmenopause
- Hormone Therapy and Heart Disease, Stroke Prevention
- Hormone Therapy and Osteoporosis
- Menopause Healthy Living
- Menopause or Aging
Links
Where may I find Links related to Hormone Therapy and Aging?
Your Country may have Links similar to:
Links
This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.- 2016 IMS Recommendations on Women’s Midlife Health and Menopause Hormone Therapy
- 9 Myths and Misunderstandings About Menopausal Hormone Therapy (MHT): 6. Myth – Complementary Medicines and Therapies Are As Effective As MHT and Safer
- 9 Myths and Misunderstandings About Menopausal Hormone Therapy (MHT): 7. Myth – Compounded Bioidentical Hormone Therapy Is Safer Than Conventional MHT
- Bioidentical Hormone Therapy
- Bioidentical Hormones Explained – A British Menopause Society Video
- Bioidentical Hormones: Are They Safer?
Combined Menopausal Hormone Therapy (MHT)
- Complementary Medicine Options for Menopausal Symptoms
- Complementary and Alternative Therapies Explained – A British Menopause Society Video
- Deciding About Hormone Therapy
- Deciding About Hormone Therapy Use
- Decidir Sobre La Hormonoterapia
- Early Menopause: Experiences and Perspectives of Women and Health Practitioners – Women’s Profiles
- Estrogen & Hormones: Postmenopausal Hormone Replacement Therapy
- Estrogen (Vaginal Route): Before Using
- Estrogen (Vaginal Route): Description and Brand Names
- HRT
- HRT and Breast Cancer: Overall Risks and Benefits Explained – A British Menopause Society Video
- HRT and the Risk of Breast Cancer Explained – A British Menopause Society Video
- Health After Menopause
- Healthy Living By Age
- Healthy Living By Age: Healthy Living In Your 40s
- Healthy Living By Age: Healthy Living In Your 50s
- Healthy Living By Age: Healthy Living In Your 60s
- Hormone Replacement Therapy (HRT) Explained – A British Menopause Society Video
- Hormone Replacement Therapy (HRT): Risks
- Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions
- Hormone Therapy: Is It Right for You?
- Hormones After Age 65 Are OK for Some Women
- Index To Drug-Specific Information [United States]
- Information About Menopause [Multiply Languages] [Videos]
- Menopausal Hormone Therapy: Preventative Medication
- Menopause
- Menopause
- Menopause
- Menopause
- Menopause FAQs: Hormone Therapy for Menopause Symptoms
- Menopause FAQs: Your Health After Menopause
- Menopause Hormone Therapy: Who Shouldn’t Take It?
- Menopause Treatment
- Menopause and Sexuality
- Menopause and Women’s Health In Later Life
- Menopause and Your Health
- Menopause – How Will It Affect My Health? [Multiply Languages] [Video]
- Menopause – Non-Hormonal Treatment Options [Multiply Languages] [Video]
- Menopause: Diagnosis & Treatment
- Menopause: Diagnosis and Management – Information for the Public: Questions To Ask About Menopause [NICE Guideline]
- Menopause: Medicines To Help You
- Menopause: Menopause – Hormone Treatments
- Menopause: Profiles – Postmenopausal [Video Interview Stories]
- NAMS 2017 Position Statement Updates Guidelines for Hormone Therapy Use
- National Center for Complementary and Integrative Health: How Safe Is This Product or Practice?
- National Center for Complementary and Integrative Health: Menopausal Symptoms In Depth
- National Center for Complementary and Integrative Health: Natural Doesn’t Necessarily Mean Safer, or Better
- National Center for Complementary and Integrative Health: Women’s Health and Complementary Approaches
- Oestrogen Only Menopausal Hormone Therapy
- Revised Global Consensus Statement on Menopausal Hormone Therapy
- Video Series-2020 – Bone Health What You Need To Know
- Video Series-2020 – How To Talk To Your Primary Care Clinician About Your Overall Health
- Video Series-2020 – What You Need To Know About Bioidentical Hormone Therapy
- Video Series-2020 – What Women Need To Know About Heart Disease
Sources
Where may I find the Sources quoted?
You may find the Sources at:
Sources
- Deciding About Hormone Therapy Use: Potential Risks. 2017:2. North American Menopause Society https://www.menopause.org/docs/default-source/for-women/menonote-deciding-about-ht-2017.pdf Accessed: 08 October 2020
- Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Recommendation Summary. 12 December 2017. U.S. Preventative Services Task Force https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication Accessed: 08 October 2020
- Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Recommendation Summary. 12 December 2017. U.S. Preventative Services Task Force https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication Accessed: 08 October 2020
- Menopause FAQs: Your Health After Menopause – Q. What can I do to prevent osteoporosis? North American Menopause Society https://www.menopause.org/for-women/menopause-faqs-your-health-after-menopause Accessed: 08 October 2020
- Menopause FAQs: Your Health After Menopause – Q. Do I have to start worrying about heart disease? North American Menopause Society https://www.menopause.org/for-women/menopause-faqs-your-health-after-menopause Accessed: 08 October 2020
- NAMS 2017 Position Statement Updates Guidelines for Hormone Therapy Use. 20 June 2017:1. North American Menopause Society https://www.menopause.org/docs/default-source/default-document-library/ht-press-release-061917.pdf Accessed: 08 October 2020
- Deciding About Hormone Therapy Use: Potential Risks. 2017:2. North American Menopause Society https://www.menopause.org/docs/default-source/for-women/menonote-deciding-about-ht-2017.pdf Accessed: 08 October 2020
- NAMS 2017 Position Statement Updates Guidelines for Hormone Therapy Use. 20 June 2017:1. North American Menopause Society https://www.menopause.org/docs/default-source/default-document-library/ht-press-release-061917.pdf Accessed: 08 October 2020
- De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Section B: General Principles Governing the Use of MHT. Climacteric, 2016;19:4:314 https://www.imsociety.org/manage/images/pdf/ba6379e868044bec13015ac2b84f2753.pdf Accessed: 08 October 2020
- NAMS 2017 Position Statement Updates Guidelines for Hormone Therapy Use. 20 June 2017:2. North American Menopause Society https://www.menopause.org/docs/default-source/default-document-library/ht-press-release-061917.pdf Accessed: 08 October 2020